On 30 June 2025, administrators were appointed to Rapid Response Revival Research Limited and several related companies, including Cellaed Life Saver Pty Ltd. In an earlier judgment referred to in this case, the Court described the group as operating in the research, development, manufacturing and sale of proprietary hand-held and mobile defibrillators and revivors. The group’s major assets included intellectual property rights, certificates, technology and workforce. The Court also recorded that the group had an extensive catalogue of registered trade marks, designs and patents across numerous jurisdictions, and that overseas buyers might be particularly interested in those assets.
That background mattered because the administrators were already engaged in a global sales campaign. They were trying to maximise returns to creditors and to preserve or enhance the value of the business offering. The earlier judgment noted, for example, that extending the convening period for the second creditors' meeting would allow intellectual property registrations to be advanced or renewed, which could improve value. So by the time this later application came before Derrington J, the sale process was already underway and the ability to transfer IP assets was commercially important.
Cellaed Life Saver Pty Ltd had a special role in the group structure. It had been appointed trustee of the CellAED IP Holding Unit Trust under a unit trust deed dated 20 November 2017. The trust was a fixed unit trust, and all units were held by Rapid Response Revival Research Limited, the group holding entity. The effect of that arrangement was that Cellaed, as trustee, owned the proprietary rights to the registered patents and designs used by the broader group.
That kind of structure is not unusual in business groups. Valuable IP is sometimes held separately from trading operations for tax, investment, financing, governance or asset protection reasons. But the legal owner of the IP is the entity that matters when a sale, insolvency or restructuring occurs. Here, the legal owner was not simply one of the operating companies. It was the trustee of the unit trust.
The trust deed then created the problem. It provided that the office of trustee would be vacated if the trustee entered administration. Once administrators were appointed to Cellaed on 30 June 2025, it was automatically removed as trustee and thereafter acted only as a bare trustee. The Court said that meant it lacked power to deal with or realise trust assets. At the same time, Cellaed had incurred about $2.5 million in liabilities as trustee, and those liabilities remained outstanding.
So the administrators faced a familiar but difficult position. The former trustee retained rights of exoneration and indemnity in relation to liabilities incurred as trustee, supported by an equitable lien over trust assets, but it no longer had power to sell those assets itself. Yet the trust assets included essential and vital assets of the business. If the administrators could not control and transfer them, the sale process for the wider group would be harder, slower and less certain.